UCSF

Tagged: PharmD Degree Program

Medicare may restrict coverage of Alzheimer's drug

Fri Jan 21, 2022

Integrative mechanisms underlying the evolution of drug resistance in oncogene-driven lung cancer: a QBI Online Seminar with Trever Bivona

Fri Jan 21, 2022
Bivona.
The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the U.S. and Ireland.

Kearney named interim dean of UCSF School of Pharmacy

Fri Jan 14, 2022
Kearney
Kaz Tsuruta

Thomas Kearney, PharmD

The search for the School’s next dean is ongoing.

Faculty members inducted into the Chan Zuckerberg Biohub Investigator Program

Thu Jan 13, 2022
Gartner holding a petri dish
Barbara Ries

Zev Gartner, PhD, was one of six School of Pharmacy faculty members to be named a Chan Zuckerberg Biohub Investigator in 2022.

Gartner, Huang, Manglik, Kortemme, Savic, and Shipman honored for visionary research endeavors

Chemistry-based strategies for investigating protein ADP-ribosylation: a QBI Online Seminar with Michael Cohen

Thu Jan 13, 2022
Cohen.
The QBI Online Seminar Series presents Michael Cohen, an associate professor in the Department of Chemical Physiology and Biochemistry at Oregon Health and Science University (OHSU). Dr. Cohen received his BS in chemistry (cum laude) from UC Irvine and a PhD in chemical biology from UC San...

Researchers pioneer new method to edit genes in human cells

Thu Jan 6, 2022

Beyond the spike protein

Mon Jan 3, 2022
Human cells dotted with viral particles
NIAID/NIH

A human cell (green) infected with SARS-CoV-2 virus particles (purple). Research from QBI has identified how the Alpha variant of the virus evades the human immune system.

Findings from QBI point to a host of viral proteins that enable SARS-CoV-2 variants to evade the immune system.

Multi-scale modelling of cellular signalling, from protein structure to control of cell state transitions: a QBI Online Seminar with Oleksii Rukhlenko

Thu Dec 16, 2021
Rukhlenko.
The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland. QBI and UCD recently signed a 5-year MOU to reinforce the links between scientists in San Francisco and Dublin, and enhance...

UCSF researchers develop a new drug regimen to combat malaria in children

Thu Dec 16, 2021
Child sitting on a bed surrounded by a bed net
UK Department for International Development

A child sits on a bed surrounded by a bed net intended to prevent mosquito bites that could transmit malaria, Kenya. A new drug regimen developed at UCSF offers children improved protection against the disease.

Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.

Five School of Pharmacy trainees earn honors from the American Society for Clinical Pharmacology & Therapeutics

Tue Dec 14, 2021
Round, oval, and oblong pills
Wikimedia Commons
PhD students and postdoctoral researchers earn the 2022 Presidential Trainee Award

Pages

Make a gift
Science is the foun­da­tion of the School of Pharmacy’s pi­o­neer­ing re­search, in­di­vid­ua­lized pa­tient care, and un­par­al­leled PharmD and PhD ed­u­ca­tion pro­grams.
© 2002–2022 The Regents of the University of California